Building Capacity, Building Rights? State Capacity and Labor Rights in Developing Countries

2015 ◽  
Vol 72 ◽  
pp. 127-139 ◽  
Author(s):  
Daniel Berliner ◽  
Anne Greenleaf ◽  
Milli Lake ◽  
Jennifer Noveck
Keyword(s):  
Developing Countries ◽  
Capacity Building ◽  
State Capacity ◽  
Labor Rights ◽  
Building Capacity

scholarly journals Assessment of the Mechanism for Mining Technology Transfer in the Area: Loopholes in ISA Practice and Its Mining Code

2021 ◽  
Vol 13 (13) ◽  
pp. 7005
Author(s):  
Yu Ning
Keyword(s):  
Developing Countries ◽  
Technology Transfer ◽  
Intellectual Property ◽  
Capacity Building ◽  
Mining Technology ◽  
Positive Approach ◽  
Commercial Exploitation ◽  
Governmental Organization ◽  
International Seabed Authority ◽  
Favorable Conditions

Draft commercial exploitation regulations have been on the agenda of the ISA since several 15-year exploration contracts expired a few years ago. Given the ineffective implementation in practice and the ignored chapter in several mining regulations on the transfer of mining technology, the future Enterprise and developing countries may take a more positive approach to the transfer of mining technology by striking a delicate balance between the provisions on the protection of intellectual property and those on capacity building under the framework of UNCLOS and the 1994 Agreement, through reciprocal and mutual beneficial means such as direct technology purchasing and investment cooperation. The International Seabed Authority, as the competent inter-governmental organization, has the duty to foster favorable conditions for such transfer.

Executive Agency and State Capacity in Development: Comparing Sino-African Railways in Kenya and Ethiopia

2021 ◽  
Author(s):  
Yuan Wang
Keyword(s):  
Developing Countries ◽  
State Capacity ◽  
Institutional Constraints ◽  
Infrastructure Projects ◽  
Individual Agency ◽  
The Individual ◽  
Executive Agency

Why do infrastructure projects that are similar in nature develop along starkly different trajectories? This question sheds light on the varying state capacity of developing countries. Divergent from structural explanations that stress external agency and institutional explanations that emphasize bureaucratic capacity, I propose a political championship theory to explain the variance in states capacity of infrastructure delivery. I argue that when a project is highly salient to leaders’ survival, leaders commit to the project; leaders with strong authority build an implementation coalition, leading to higher effectiveness. I trace the process of the Standard Gauge Railway in Kenya and Addis-Djibouti Railway in Ethiopia, relying on over 180 interviews. This research highlights the individual agency within structural and institutional constraints, a previously understudied area in state capacity.

Inclusion Wheel: Tool for Building Capacity and Public Health Leaders to Serve People With Disabilities

2018 ◽  
Vol 21 (2) ◽  
pp. 209-218
Author(s):  
Adriane K. Griffen ◽  
Kristina Risley ◽  
Michael Petros ◽  
Christina R. Welter
Keyword(s):  
Public Health ◽  
Capacity Building ◽  
Community Of Practice ◽  
Underserved Populations ◽  
Awareness Training ◽  
Building Capacity ◽  
Demographic Groups ◽  
Disability Awareness ◽  
Reflection Time ◽  
Priority Population

Public health leaders need to influence change to serve underserved populations, such as people who have a disability. Action research was conducted with a community of practice (CoP) from Ohio to examine readiness, capacity building, and capacity factors needed for public health partners to more fully include people who have a disability (PWD) in state smoking cessation efforts. Five conditions fostered readiness, capacity building, and capacity among public health partners to include PWD: (1) successful timing of effort, (2) facilitation of discussions, (3) systematic reflection, (4) sufficient support, and (5) personal commitment of participants. Nine factors of readiness, capacity building, and capacity influenced inclusion of PWD: (1) positive perception and quality interactions with partners, (2) contact with organizations, (3) recognition of need to coordinate, (4) engagement in a network, (5) practical collaboration experience, (6) continuing education, (7), critical reflection time, (8) dedicated staff, and (9) knowledge of priority population. Readiness, capacity, and capacity building were interconnected and supported inclusion of PWD in public health efforts. Ohio public health partners used these factors and conditions to achieve the first mandatory disability awareness training for all National Jewish Health Quitline counselors. Future efforts addressing other specific demographic groups that experience health disparities can use these findings.

scholarly journals Comparative Advantages of National Pharmaceutical Industries through the Prism of New Indicators

2020 ◽  
Vol 89 (2-3) ◽  
pp. 48-58
Author(s):  
O. B. Salikhova
Keyword(s):  
Developing Countries ◽  
Pharmaceutical Industry ◽  
Capacity Building ◽  
Value Added ◽  
Global Market ◽  
High Tech ◽  
Medical Products ◽  
Comparative Advantages ◽  
Pharmaceutical Industries ◽  
Production Facilities

Specific ways of the emergence of new actors in the global market of pharmaceutical goods is investigated, with substantiating the role of transnational corporations (TNC), their investment and technologies in establishing pharmaceutical industries in developing countries. The cases of Puerto Rico and Ireland are taken in order to demonstrate the background for expansion of manufacturing of medicines and medical products and analyze the tendencies in their export capacity building. The factors making pharmaceutical TNC transfer production facilities to India and China are substantiated and implications of this process are highlighted. It is revealed that due to the production internationalization, countries that had been net importers of pharmaceuticals just several decades ago have joined the group of key suppliers to external markets. Because American and European TNC are leading in the pharmaceutical industry by R&D expenditure, they are the principal holders of advanced technologies in the industry. It follows that manufacturing of medicines and medical products in most part of countries either directly or indirectly depend on innovative products of TNC and their technology transfer via various channels (both licensing and imports of components, active pharmaceutical ingredients in particular). It is shown that with the emergence of new market actors coming from developing countries, traditional approaches to determining comparative advantages of counties in the global trade need to be improved. The cases of countries that are recipients of foreign technologies, on which territories powerful high tech pharmaceutical production facilities with high shares of intermediate consumption and heavy export supplies are located due to TNC investment or local public-private capital, give evidence that the classical RCA indicator allows to measure visible comparative advantages in the trade in goods rather than revealed ones. It is proposed that analyses of advantages at country level should include the indicator of high tech goods supplies, to provide for a more accurate description of the innovation component in advanced industries. A new approach to the assessment of comparative advantages of high tech pharmaceutical manufacturing is proposed and tested, which is based on the principle of specialization and use of the ratio of Comparative Advantage in Value Added Activity (CAVA) in particular. It is revealed that the pharmaceutical industry of Ireland, Jordan, Singapore, India or Columbia, with reliance on foreign investment and technologies, could gain advantages in value added creation and dominate the national economies. It is shown that Ukraine is enhancing the advantages in value added creation in the pharmaceutical industry; is it substantiated that due to low R&D and innovation performance and heavy dependence on imported components, capacity building of this industry and its current advantages result from global tendencies and global market conjunctures rather than from the implementation of the national science & technology priorities. According to the author’s recommendation, the proposed approach to determining comparative advantages in value added creation should be used for the assessment of other high tech industries, apart from the pharmaceutical industry, and that is should be supplemented by statistical tools for analysis of foreign trade in finished and intermediate high tech goods.

Sign in / Sign up

Export Citation Format

Share Document